Procter & Gamble Health L

Procter & Gamble Health L (PGHL) is a small-cap Healthcare company valued at ₹8,632 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Procter & Gamble Health L last traded at ₹5,199.5, modestly up 0.98% on the day.

Recent developments

On 2026-08-27, the company announced a dividend of ₹45.00 per share, with an ex-date of that day. On 2026-02-12, a larger dividend of ₹160.00 per share was declared, with an ex-date of that day. Domestic institutional holding fell by 1.24 percentage points in the quarter, while foreign institutional holding rose by 0.13 percentage points.

Financial performance

The company's annual revenue rose 50.7% to ₹1,408 crore, while annual net profit increased 39.7% to ₹327 crore. In the latest quarter, revenue grew 7.3% year-over-year to ₹364 crore, and net profit surged 45.7% to ₹96 crore, outpacing revenue growth.

Valuation multiples

The stock trades at 26.4 times earnings, a discount to the Healthcare median of 32.0, 17.16 times book value. It yields 3.8%.

Things to watch

The net profit margin narrowed 1.8 percentage points to 23.2%, down from 25.1% the prior year. The stock is 23.2% below its 52-week high, and promoter holding remains at 51.82% as of 2026-06-30. Domestic institutional holding decreased in the quarter.

Where it stands

The company reported strong annual growth in both revenue and net profit, with a notable jump in the latest quarter's net profit. The stock is trading 23.2% below its 52-week high, and the net profit margin has declined slightly. Domestic institutional holding dropped in the quarter, while foreign institutional holding increased.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.